Brief: LBT Innovations Says Astrazeneca Partners LBT For Apas Pharma Development
09/01/2023 01:19
Jan 9 (Reuters) - LBT Innovations Ltd LBT.AX :
* ASTRAZENECA PARTNERS LBT FOR APAS PHARMA DEVELOPMENT
* CO ENGAGED BY ASTRAZENECA FOR FULL PRODUCT DEVELOPMENT FOR
ITS
APAS PHARMA PRODUCT
* UNDER PROJECT, ASTRAZENECA WILL FUND DEVELOPMENT OF APAS
PHARMA
ANALYSIS MODULE AND VALIDATE FINAL PRODUCT FOR THEIR PROCESSES
Source text for Eikon: ID:nASX8hByVW
Further company coverage: LBT.AX
Recent news on Clever Culture Systems
See all newsBrief: Clever Culture Systems Says Novo Nordisk Expand Use Of Apas Independence
Australia's Clever Culture Systems jumps nearly 29% on Novo Nordisk order
Australia's Clever Culture Systems falls after swinging to annual loss
Brief: Clever Culture Systems Says No Dividend Proposed For FY2026
Brief: Clever Culture Systems Ltd Says CSL Orders APAS Independence For Global QC Operations